Assessing the acceptability, appropriateness, and feasibility of a group therapy program for people with stage III melanoma (MELGROUP): a pilot study

Not Applicable

• Conditions: Stage III Melanoma; Cancer - Malignant melanoma

• Registration Number: ACTRN12623000815662
• Lead Sponsor: Melanoma Institute Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-28
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

People with histologically confirmed stage III melanoma, who:
•Were recently diagnosed with stage III melanoma (within the previous 6 months).
•Are proficient in English.
•Are 18 years or older at the time of study enrolment.
•Are able to attend 8 fortnightly online or in-person group psychotherapy sessions.
•Have consented to be part of the MIA’s Melanoma Research Database, which indicated willingness to be contacted for research purposes.
•Provide written informed consent.

Exclusion Criteria

•People diagnosed with stage 0, I, II, IV, metastatic ocular, mucosal, or other non-cutaneous forms of melanoma.
•People with a medically diagnosed psychiatric or cognitive conditions which can interfere with the ability to meet project’s requirements or provide informed consent.
•People with a previous or current diagnosis of a different (non-melanoma) cancer.

Study & Design

• Study Type: Interventional
• Study Design: Not specified